Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arfolitixorin versus leucovorin with 5-fluorouracil, oxaliplatin, and bevacizumab in first-line advanced colorectal cancer
2017-004154-41Phase 3Terminated
- Sponsor
- Isofol Medical
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arfolitixorin in colorectal cancer (CRC), sponsored by Isofol Medical. Started Oct 2018; status: terminated.
02
Drugs
arfolitixorin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2017-004154-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004154-41.